Merck Life Science A/S: Financial statements 2015
CVR: 20830131
Source: annual report 2015, Danish Business Authority
01/01/2015 – 31/12/2015
Merck Life Science A/S (CVR 20830131) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 34,274,758 and a net result of DKK 7,405,593 compared with DKK 3,885,492 the year before. That is an increase of 24.5% compared with the year before. Equity in the 2015 report amounted to DKK 35,503,243. The solvency ratio was 73%. The company had 17 employees in the financial year.
- Gross Profit
- DKK 34,274,758
- Profit/Loss
- DKK 7,405,593
- Equity
- DKK 35,503,243
- Total Assets
- DKK 48,656,774
- Employees
- 17
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2015 | - | 34.3M | 7.4M | 35.5M | 17 |
| 2014 | - | 27.5M | 3.9M | 28.1M | - |
| 2013 | - | 26M | 4.2M | 24.2M | - |
| 2012 | 25.8M | 17.1M | 4.3M | 20M | - |
Official annual report
How creditworthy is Merck Life Science A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2015
As of September 15, 2015, Lutz Schraishuhn has joined the board of directors of Merck Life Science A/S.
As of September 15, 2015, Søren Høegh has left the board of directors of Merck Life Science A/S.
As of September 15, 2015, Lars Ohrberg is registered as adm. dir. of Merck Life Science A/S.
As of September 15, 2015, Søren Høegh has stepped down as director of Merck Life Science A/S.
Merck Life Science A/S has published its annual report for 2014. Gross profit came to DKK 27,527,082, and the net result was DKK 3,885,492.
About Merck Life Science A/S
Merck Life Science A/S is a Danish company of the type Aktieselskab based in Søborg, founded in 1998. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SIGMA-ALDRICH DENMARK A/S and SIGMA-ALDRICH DENMARK ApS. The management consists of Janecke Stokkebokjær Lundring. The board consists of Anders Gerner Petersen (chair), Janecke Stokkebokjær Lundring and Tiina Marjatta Puhakka. The company is owned by Merck Life Science N.V. The company has 24 employees (2026). In 2025, the company reported revenue of DKK 1,748,796,583 and a net result of DKK 79,492,665 compared with DKK 66,730,278 the year before. Equity in the 2025 report amounted to DKK 226,078,413.